SCHEMBL10187283

SCHEMBL10187283

Nc1cc(-c2ccc3c(c2)OCO3)ncn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.57
ADORA1 P30542 2/20 0.57
CLK4 Q9HAZ1 9/20 0.54
ALDH1A1 P00352 7/20 0.54
HSD17B10 Q99714 6/20 0.54
CYP1A2 P05177 5/20 0.54
CYP3A4 P08684 5/20 0.54
CYP2D6 P10635 4/20 0.54
CYP2C19 P33261 4/20 0.54
LMNA P02545 3/20 0.54
ALOX15 P16050 2/20 0.54
USP2 O75604 2/20 0.54
CASP7 P55210 1/20 0.54
KMO O15229 1/20 0.53
ADORA3 P0DMS8 1/20 0.52
DYRK1A Q13627 5/20 0.52
CHEK1 O14757 1/20 0.52
AURKA O14965 1/20 0.52
DAPK3 O43293 1/20 0.52
JAK2 O60674 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15533860 0.81 CLK4 (0.57) ADORA2AADORA1CLK4ALDH1A1HSD17B10
SCHEMBL18650958 0.81 CLK4 (0.58) ADORA2AADORA1CLK4ALDH1A1HSD17B10
SCHEMBL21565688 0.78 CLK4 (0.49) ADORA2AADORA1CLK4ALDH1A1HSD17B10
SCHEMBL21565699 0.77 CLK4 (0.51) ADORA2AADORA1CLK4ALDH1A1HSD17B10
SCHEMBL19596599 0.77 CLK4 (0.51) ADORA2AADORA1CLK4ALDH1A1HSD17B10
SCHEMBL14741834 0.76 KMO (0.57) CLK4ALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL20380088 0.75 KDM4E (0.59) ADORA2AADORA1CLK4ALDH1A1HSD17B10
SCHEMBL30501033 0.75 KDM4E (0.59) ADORA2AADORA1CLK4ALDH1A1HSD17B10
SCHEMBL14663218 0.74 KMO (0.64) ADORA2AADORA1CLK4ALDH1A1HSD17B10
SCHEMBL10187346 0.73 FYN (0.59) ADORA2AADORA1CLK4ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012001107-A1 PIPERIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-01-05 WO disclosed